Journal of Anaesthesiology Clinical Pharmacology

CASE REPORT
Year
: 2013  |  Volume : 29  |  Issue : 2  |  Page : 248--251

Aortic valve replacement in a patient with systemic lupus erythematosus


Bhuvnesh Kansara1, Ajmer Singh1, Anil Karlekar1, Yugal K Mishra2 
1 Department of Anesthesiology, Escorts Heart Institute and Research Centre Ltd, Okhla Road, New Delhi, India
2 Department of Cardiac Surgery, Escorts Heart Institute and Research Centre Ltd, Okhla Road, New Delhi, India

Correspondence Address:
Bhuvnesh Kansara
Escorts Heart Institute and Research Centre Ltd., Okhla Road, New Delhi 110 025
India

Valvular heart disease in systemic lupus erythematosus (SLE) is associated with substantial morbidity and mortality. Current therapy includes symptomatic measures and valve replacement. SLE can present major challenges because of accrued organ damage, coagulation defects and complex management regimes. The peri-operative goals are to maintain strict asepsis, avoid use of nephrotoxic drugs and thereby renal insult, and to promote early ambulation post-operatively.


How to cite this article:
Kansara B, Singh A, Karlekar A, Mishra YK. Aortic valve replacement in a patient with systemic lupus erythematosus.J Anaesthesiol Clin Pharmacol 2013;29:248-251


How to cite this URL:
Kansara B, Singh A, Karlekar A, Mishra YK. Aortic valve replacement in a patient with systemic lupus erythematosus. J Anaesthesiol Clin Pharmacol [serial online] 2013 [cited 2021 May 13 ];29:248-251
Available from: https://www.joacp.org/article.asp?issn=0970-9185;year=2013;volume=29;issue=2;spage=248;epage=251;aulast=Kansara;type=0